I am looking for other points of view regarding this Quality Incident process approval presented to my Quality team. I am open to being robust but I am not in agreement with not having to initiate a deviation from an established process or tracking a deviation in a memo. We are a company that performs packaging and labeling of clinical trial materials which are distributed throughout the world to patients in clinical trial studies.
I appreciate your feedback.
I appreciate your feedback.